MXCT
MAXCYTE, INC.
Key Financials
Gross Profit
$26.8M
↓ 15.0%
Net Income
$-44630000
↓ 8.7%
Operating Income
$-51897000
↓ 1.4%
EPS (Diluted)
$-0.42
↓ 7.7%
Total Assets
$202.5M
↓ 15.4%
Total Liabilities
$31.0M
↓ 6.6%
Revenue
$33.0M
↓ 14.5%
Shareholders' Equity
$171.5M
↓ 16.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 4/17/2026 | View on SEC |
| S-8 | 4/15/2026 | View on SEC |
| 4 | 4/10/2026 | View on SEC |
| 3 | 4/10/2026 | View on SEC |
| SCHEDULE 13G/A | 4/10/2026 | View on SEC |
| 4 | 3/31/2026 | View on SEC |
| 8-K | 3/27/2026 | View on SEC |
| SCHEDULE 13G/A | 3/27/2026 | View on SEC |
| 10-K | 3/25/2026 | View on SEC |
| 8-K | 3/24/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | MXCT |
| Company Name | MAXCYTE, INC. |
| CIK | 1287098 |
| Sector | Services-Commercial Physical & Biological Research |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 8731 |
| SIC Description | Services-Commercial Physical & Biological Research |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 301-517-5556 |